Home 2021
Yearly Archives: 2021
A cancer drug repurposed to treat malaria has been shown to be nearly 100%...
A cancer drug repurposed to treat malaria has been shown to be nearly 100% effective in helping defeat the disease in just three days,...
SARS-CoV-2 Alters Human Host RNA To Improve Viral Fitness
Study findings by researchers from the Agency for Science, Technology and Research-Singapore ( (A*STAR), Duke-NUS Medical School-Singapore and the Yong Loo Lin School of Medicine...
Maternal voice induces an increase of oxytocin in premature babies reducing pain
A baby born prematurely often has to be separated from its parents and placed in an incubator in intensive care. For several weeks, he...
L’iniezione di BNT162b2 COVID-19 di Pfizer aumenta il rischio di miocardite di tre volte
In modo allarmante un nuovo studio condotto da ricercatori del Clalit Research Institute-Israele, Ben-Gurion University of the Negev, Be'er Sheva-Israel, Harvard Medical School-USA e...
La variante Delta AY12 del COVID-19 si sta diffondendo rapidamente in India e l’AY3...
L'INSACOG o il consorzio India SARS-CoV-2 Genome riportano la prevalenza della sottolinea variante Delta AY12 in India che è stata collegata a un'ondata di...
COVID-19 Delta Variant A.Y.12 Is Fast Spreading In India and A.Y.3 Is Able To...
INSACOG or the India SARS-CoV-2 Genome consortium reports prevalence of the Delta variant sub-lineage A.Y.12 in India that has been linked to a COVID-19...
Pfizer’s BNT162b2 COVID-19 Shot Increases Risk of Myocarditis By Threefold
Alarmingly a new study by researchers from Clalit Research Institute-Israel, Ben-Gurion University of the Negev, Be’er Sheva-Israel, Harvard Medical School-USA and Boston Children’s Hospital-USA...
New South African SARS-CoV-2 variant called C.1.2 could change the course of the pandemic...
outh African researchers from the National Institute for Communicable Diseases (NICD), University of the Witwatersrand, University of Cape Town, University of Pretoria, University of...
French Study Claims That ADE Is Occurring In Delta Variant Infections
A new study by French researchers from Aix-Marseille Université has alarmingly found that ADE or antibody dependent enhancement is indeed occurring in infections with...
Fluvoxamina: un antidepressivo emergente come farmaco leader per il trattamento del COVID-19
Farmaci COVID-19 : la fluvoxamina, un farmaco antidepressivo poco costoso, sta ora emergendo come potenziale candidato da riproporre per il trattamento del COVID-19.
Ci sono speculazioni...
Uno studio francese afferma che l’ADE si verifica nelle infezioni della variante Delta
Un nuovo studio condotto da ricercatori francesi dell'Università di Aix-Marseille ha scoperto in modo allarmante che l'ADE o il potenziamento dipendente da anticorpi si...
Fluvoxamine: An Antidepressant Emerging As A Leading Drug To Treat COVID-19
COVID-19 Drugs: Fluvoxamine, an inexpensive anti-depressant drug is now emerging as a potential candidate to be repurposed to treat COVID-19.
Speculations are adrift that Canada...
The new alkali metal-chlorine batteries can store up to six times more charge than...
An international team of researchers led by Stanford University have developed rechargeable batteries that can store up to six times more charge than ones...
One nanolitre Biosupercapacitors (BSCs) provides energy for biomedical applications
The miniaturization of microelectronic sensor technology, microelectronic robots or intravascular implants is progressing rapidly. However, it also poses major challenges for research.
One of...
Spinal cord stimulation may drastically reduce chronic back pain
A new approach to spinal cord stimulation may drastically reduce chronic back pain, a small pilot study suggests.
The study, of 20 patients with stubborn...
